Pharmacological and genetic inhibition of the IGF1R-PI3K-AKT pathway reverses CAM-DR by promoting EZH2 dephosphorylation and H3K27 hypermethylation both in vitro and in refractory murine MM models [95]. The gene discussed is EZH2; the disease is Miyoshi myopathy.